ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,072Medicare Part D Prescriptions Filled, Including Refills

Rank: 132 out of 2888

$966K Total Retail Price of All Prescriptions

Rank: 232 out of 2888

677 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

18% of this provider’s 677 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 15,882 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
SIMVASTATIN 875 795 1 2
AMLODIPINE BESYLATE 865 828 2 5
PRAVASTATIN SODIUM 629 531 3 12
METFORMIN HCL 567 483 4 8
LISINOPRIL 561 489 5 3
LEVOTHYROXINE SODIUM 529 482 6 1
HYDROCODONE-ACETAMINOPHEN 488 352 S3 7 4
METOPROLOL SUCCINATE 356 335 8 11
TAMSULOSIN HCL 351 339 9 29
METOPROLOL TARTRATE 313 297 10 10
OMEPRAZOLE 306 275 11 7
NEXIUM 292 221 12 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 282 277 13 28
JANUVIA 266 202 14 48
GLIPIZIDE 265 225 15 50
METFORMIN HCL ER 258 235 16 53
LOVASTATIN 247 247 17 41
ATORVASTATIN CALCIUM 227 190 18 9
CRESTOR 217 200 19 20
FUROSEMIDE 215 200 20 6
GABAPENTIN 212 187 21 13
PANTOPRAZOLE SODIUM 201 175 22 33
DONEPEZIL HCL 196 196 23 26
ENABLEX 189 185 24 269
HYDROCHLOROTHIAZIDE 171 165 25 15
NIFEDIPINE ER 165 146 26 76
SERTRALINE HCL 164 99 27 27
CLOPIDOGREL 164 161 27 30
RAMIPRIL 154 133 29 73
TERAZOSIN HCL 152 129 30 152
BENAZEPRIL HCL 144 136 31 77
FLUTICASONE PROPIONATE 137 122 32 32
PROMETHAZINE HCL 137 136 R 32 96
GLYBURIDE 134 111 R 34 58
ZOLPIDEM TARTRATE 131 95 35 17
ACTOS 127 98 36 108
ATENOLOL 127 108 36 25
CARVEDILOL 124 112 38 21
FINASTERIDE 122 122 39 102
RANITIDINE HCL 118 90 40 56
GLYBURIDE-METFORMIN HCL 114 93 R 41 64
BENICAR 111 106 42 138
TRIAMTERENE-HCTZ 108 83 43 63
CITALOPRAM HBR 104 88 44 24
BENICAR HCT 102 95 45 181
PLAVIX 102 100 45 40
GLIPIZIDE XL 101 86 47 205
LOSARTAN POTASSIUM 97 80 48 18
CILOSTAZOL 96 91 49 165
GLIPIZIDE ER 95 86 50 107
ENALAPRIL MALEATE 95 84 50 49
FENOFIBRATE 95 82 50 65
CAPTOPRIL 91 91 53 225
ISOSORBIDE MONONITRATE ER 90 90 54 51
LOSARTAN-HYDROCHLOROTHIAZIDE 87 74 55 46
ESCITALOPRAM OXALATE 85 73 56 62
PROAIR HFA 85 67 56 71
AMLODIPINE BESYLATE-BENAZEPRIL 84 57 58 67
SPIRIVA 81 81 59 79
COLCRYS 80 69 60 295
ALENDRONATE SODIUM 77 65 61 23
CYCLOBENZAPRINE HCL 76 66 R 62 68
TRAMADOL HCL 76 57 62 16
NAMENDA 73 73 64 34
DIOVAN 70 70 65 35
LANTUS SOLOSTAR 70 53 65 92
CIPROFLOXACIN HCL 68 63 67 47
WARFARIN SODIUM 67 64 68 22
AZITHROMYCIN 67 53 68 38
GLIMEPIRIDE 66 65 70 36
LANTUS 65 51 71 45
NIFEDICAL XL 64 64 72 190
INDAPAMIDE 64 64 72 235
POTASSIUM CHLORIDE 63 63 74 14
ECONAZOLE NITRATE 62 56 75 544
TRICOR 61 54 76 91
MECLIZINE HCL 60 60 77 122
VOLTAREN 60 59 77 157
MIRTAZAPINE 57 57 79 54
SYMBICORT 55 51 80 142
ACTONEL 55 55 80 149
DILTIAZEM ER 54 44 82 182
HYDRALAZINE HCL 54 43 82 59
BENAZEPRIL-HYDROCHLOROTHIAZIDE 54 54 82 254
MELOXICAM 53 38 85 31
CLONIDINE HCL 53 46 85 39
NIFEDIAC CC 52 51 87 300
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 3, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.